These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2783891)

  • 21. Activation of tumoricidal properties in macrophages and inhibition of experimentally-induced murine metastases by a new synthetic acyltripeptide, FK-565.
    Inamura N; Nakahara K; Kino T; Gotoh T; Kawamura I; Aoki H; Imanaka H; Sone S
    J Biol Response Mod; 1985 Aug; 4(4):408-17. PubMed ID: 4031951
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aclacinomycin inhibits suppressor cells in vivo and in vitro.
    Orbach-Arbouys S; Andrade-Mena CE; Berardet M; Mathe G
    Behring Inst Mitt; 1984 May; (74):258-61. PubMed ID: 6236791
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunoactive peptides, FK-156 and FK-565. I. Enhancement of host resistance to microbial infection in mice.
    Mine Y; Yokota Y; Wakai Y; Fukada S; Nishida M; Goto S; Kuwahara S
    J Antibiot (Tokyo); 1983 Aug; 36(8):1045-50. PubMed ID: 6415029
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhancement of various non-specific immune effector functions in mice by local injection of aclacinomycin A adsorbed onto activated carbon particles (ACR-CH).
    Sakakura C; Takahashi T; Hagiwara A; Yamane T; Itoh M; Shobayashi S; Sasaki S; Ozaki K; Tsujimoto H
    Int J Immunopharmacol; 1993 Feb; 15(2):245-54. PubMed ID: 8468121
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation by a new synthetic acyltripeptide and its analogs entrapped in liposomes of rat alveolar macrophages to the tumor cytotoxic state.
    Sone S; Mutsuura S; Ogawara M; Utsugi T; Tsubura E
    Cancer Immunol Immunother; 1984; 18(3):169-73. PubMed ID: 6568873
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antitumor effects of novel immunoactive peptides, FK-156 and its synthetic derivatives.
    Izumi S; Nakahara K; Gotoh T; Hashimoto S; Kino T; Okuhara M; Aoki H; Imanaka H
    J Antibiot (Tokyo); 1983 May; 36(5):566-74. PubMed ID: 6192122
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and adjuvant activity of FK-156 analogues: acyl derivatives of N-[N2-(L-alanyl-gamma-D-glutamyl)-2(L),2'(D)-diamino-1-pimeloyl ]glycine.
    Okada S; Takeno H; Hemmi K; Kitaura Y; Hashimoto M
    Chem Pharm Bull (Tokyo); 1985 Feb; 33(2):889-92. PubMed ID: 4017131
    [No Abstract]   [Full Text] [Related]  

  • 28. Recent studies on antibiotics and small molecular immunomodulators with potential usefulness in treating lung cancer: Part I - Antitumor antibiotics and their derivatives.
    Umezawa H
    Int J Clin Pharmacol Ther Toxicol; 1982 Jan; 20(1):12-8. PubMed ID: 6173340
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies on a new immunoactive peptide, FK-156. II. Fermentation, extraction and chemical and biological characterization.
    Gotoh T; Nakahara K; Nishiura T; Hashimoto M; Kino T; Kuroda Y; Okuhara M; Kohsaka M; Aoki H; Imanaka H
    J Antibiot (Tokyo); 1982 Oct; 35(10):1286-92. PubMed ID: 6757224
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Studies on structure-activity relationships of FK-156, an immunostimulating peptide, and related compounds. II. Synthesis of N2-(gamma-D-glutamyl)-2(L), 2'(D)-diaminopimelic acid as the minimal essential structure of FK-156.
    Takeno H; Okada S; Yonishi S; Hemmi K; Nakaguchi O; Kitaura Y; Hashimoto M
    Chem Pharm Bull (Tokyo); 1984 Aug; 32(8):2932-41. PubMed ID: 6518579
    [No Abstract]   [Full Text] [Related]  

  • 31. Up-regulation of induction of lymphokine (IL-2)-activated killer (LAK) cell activity by FK-565 and cisplatin.
    Basu S; Sodhi A; Singh SM; Suresh A
    Immunol Lett; 1991 Mar; 27(3):199-204. PubMed ID: 2060971
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of human blood monocytes in up-regulation of lymphokine (interleukin-2)-activated killer cell activity with cisplatin and FK-565.
    Sodhi A; Basu S
    Nat Immun; 1992; 11(2):105-16. PubMed ID: 1498519
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence of the role of protein kinase C during aclacinomycin induction of erythroid differentiation in K562 cells.
    Gillet R; Devemy E; Dupont C; Billat C; Jeannesson P; Trentesaux C
    FEBS Lett; 1999 Jul; 454(3):331-4. PubMed ID: 10431833
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The in vitro action of FK 565, bleomycin and cyclosporin A on different cell populations, with respect to the release of GM-CSF in the mouse.
    Blaney BA; Hasan SI; Koe LA; Turk JL
    Int J Immunopharmacol; 1993 Nov; 15(8):853-63. PubMed ID: 7504660
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced functional capacity of the peritoneal macrophages as antigen presenting cells after aclacinomycin treatment in mice.
    Bravo-Cuellar A; Astengo-Osuna C; Daneri-Navarro A; Hernández-Flores G; Gómez-Contreras PC; Ramos-Zepeda R; Orbach-Arbouys S
    Biomed Pharmacother; 1997; 51(4):181-4. PubMed ID: 9207987
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aclacinomycin A stabilizes topoisomerase I covalent complexes.
    Nitiss JL; Pourquier P; Pommier Y
    Cancer Res; 1997 Oct; 57(20):4564-9. PubMed ID: 9377570
    [TBL] [Abstract][Full Text] [Related]  

  • 37. N2-(gamma-D-Glutamyl)-meso-2(L),2'(D)-diaminopimelic acid as the minimal prerequisite structure of FK-156: its acyl derivatives with potent immunostimulating activity.
    Kitaura Y; Nakaguchi O; Takeno H; Okada S; Yonishi S; Hemmi K; Mori J; Senoh H; Mine Y; Hashimoto M
    J Med Chem; 1982 Apr; 25(4):335-7. PubMed ID: 7069711
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of anticancer drugs on the release of TGF-beta in vitro.
    Kassem SM; Blaney BA; Turk JL
    Immunopharmacol Immunotoxicol; 1994 Nov; 16(4):473-96. PubMed ID: 7533174
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aclacinomycin X, a novel anthracycline antibiotic produced by Streptomyces galilaeus ATCC 31133.
    Kim HS; Kim YH; Yoo OJ; Lee JJ
    Biosci Biotechnol Biochem; 1996 May; 60(5):906-8. PubMed ID: 8704322
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potentiated immune responses after administration of aclacinomycin.
    Orbach-Arbouys S; Andrade-Mena CE; Berardet M; Mathe G
    Int Arch Allergy Appl Immunol; 1982; 68(2):117-21. PubMed ID: 7042586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.